To test the functional relevance of mMCP4 upregulation we next used NGF and BDNF neutralizing antibodies, as this treatment has been shown to successfully neutralize neurogenic inflammation effects in allergic dermatitis [16]. Here, BDNF is linked to atopic eczema.